The authors compared the plasmatic Hcy–CRP levels, carotid plaques and NIH stroke scale/scores (NIHSS) between the two groups, with the following promising results: mecobalamin reduced plasmatic Hcy, the levels of plasma inflammatory factors and the volume of carotid artery plaques, resulting in a more significant functional recovery [37]. Here, CRP is linked to stroke disorder.